187 related articles for article (PubMed ID: 1826278)
21. A new association of ethinylestradiol (0.035 mg) cyproterone acetate (2 mg) in the therapy of polycystic ovary syndrome.
Falsetti L; Dordoni D; Gastaldi C; Gastaldi A
Acta Eur Fertil; 1986; 17(1):19-25. PubMed ID: 2941960
[TBL] [Abstract][Full Text] [Related]
22. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
Sahin Y; Bayram F; Keleştimur F; Müderris I
J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
[TBL] [Abstract][Full Text] [Related]
23. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Evaluation of the clinical effect].
Pedersen IM; Nielsen DR; Larsen J; Starup J
Ugeskr Laeger; 1985 Aug; 147(33):2594-6. PubMed ID: 2933858
[No Abstract] [Full Text] [Related]
24. Cyproterone acetate as initial treatment and maintenance therapy for hirsutism.
Holdaway IM; Croxson MS; Ibbertson HK; Sheehan A; Knox B; France J
Acta Endocrinol (Copenh); 1985 Aug; 109(4):522-9. PubMed ID: 2930987
[TBL] [Abstract][Full Text] [Related]
25. Cyproterone acetate: a study involving two volunteers with idiopathic hirsutism.
Barnes EW; Irvine WJ; Hunter WM; Ismail AA
Clin Endocrinol (Oxf); 1975 Jan; 4(1):65-73. PubMed ID: 1122656
[TBL] [Abstract][Full Text] [Related]
26. Steroid inhibitors of androgen-potentiated actions on skin.
Ebling FJ; Randall VA
J Steroid Biochem; 1983 Jul; 19(1B):587-90. PubMed ID: 6224973
[TBL] [Abstract][Full Text] [Related]
27. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
Barth JH; Cherry CA; Wojnarowska F; Dawber RP
Clin Endocrinol (Oxf); 1991 Jul; 35(1):5-10. PubMed ID: 1832346
[TBL] [Abstract][Full Text] [Related]
28. The effects of reverse sequential anti-androgen therapy (cyproterone acetate and ethinyl estradiol) on hematological parameters.
Parr JH; Seed M; Godsland I; Wynn V
J Endocrinol Invest; 1987 Jun; 10(3):237-9. PubMed ID: 2957418
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
Sahin Y; Dilber S; Keleştimur F
Fertil Steril; 2001 Mar; 75(3):496-500. PubMed ID: 11239530
[TBL] [Abstract][Full Text] [Related]
30. Antiandrogens and hirsutism.
Biffignandi P; Molinatti GM
Horm Res; 1987; 28(2-4):242-9. PubMed ID: 2969862
[TBL] [Abstract][Full Text] [Related]
31. [Adrenal reactivity to prolonged-action ACTH in hirsute women treated with 50 mg of cyproterone acetate combined with percutaneous estradiol].
Bercovici JP; Nahoul K; Tater D; Scholler R
Ann Endocrinol (Paris); 1986; 47(2):115-8. PubMed ID: 3026229
[TBL] [Abstract][Full Text] [Related]
32. [Hirsutism treated with cyproterone acetate and ethinyl estradiol. Influence on androgens in the serum and urine and on urinary cortisol].
Nielsen DR; Larsen J; Pedersen IM; Starup J
Ugeskr Laeger; 1985 Aug; 147(33):2589-93. PubMed ID: 2933857
[No Abstract] [Full Text] [Related]
33. [Treatment of hirsutism by the long-term administration of the anti-androgen cyproterone acetate].
Stárka L; Hampl R
Cas Lek Cesk; 1988 Jun; 127(25):790-3. PubMed ID: 2970298
[No Abstract] [Full Text] [Related]
34. [Long-term treatment of virilized women with cyproterone acetate (author's transl)].
Abrahamsson L; Hackl H; Lindström B; Sogn J
Wien Klin Wochenschr; 1981 Sep; 93(17):552-6. PubMed ID: 6458162
[TBL] [Abstract][Full Text] [Related]
35. [Cyproterone acetate and spironolactone compared in the therapy of female hirsutism].
Suraci C; Costa C; De Pedrini P
Clin Ter; 1983 Mar; 104(6):463-7. PubMed ID: 6221860
[No Abstract] [Full Text] [Related]
36. [Anti-androgens. Their use in dermatology].
Montero ED; Arevalo A; Michelotti M
Med Cutan Ibero Lat Am; 1981; 9(4):275-84. PubMed ID: 6456390
[TBL] [Abstract][Full Text] [Related]
37. The treatment of essential hirsutism in women with cyproterone acetate and ethinyl estradiol. Clinical and endocrine effects in 10 cases.
Frey H; Aakvaag A
Acta Obstet Gynecol Scand; 1981; 60(3):295-300. PubMed ID: 6455899
[TBL] [Abstract][Full Text] [Related]
38. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
[TBL] [Abstract][Full Text] [Related]
39. Effect of cyproterone acetate orally on hair density and diameter and endocrine factors in women with idiopathic hirsutism.
Peereboom-Wynia JD; Boekhorst JC
Dermatologica; 1980; 160(1):7-16. PubMed ID: 7188692
[TBL] [Abstract][Full Text] [Related]
40. Androgen metabolism in hirsute patients treated with cyproterone acetate.
Mowszowicz I; Wright F; Vincens M; Rigaud C; Nahoul K; Mavier P; Guillemant S; Kuttenn F; Mauvais-Jarvis P
J Steroid Biochem; 1984 Mar; 20(3):757-61. PubMed ID: 6231428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
